Otsuka Looks To IPO To Fund Overseas Expansion
This article was originally published in PharmAsia News
Executive Summary
Otsuka Holdings, the parent company of Japan's fifth-largest pharmaceutical company Otsuka Pharmaceutical, could go public on the Tokyo Stock Exchange within the year
You may also be interested in...
Otsuka Plans $2.8 Billion IPO To Feed Global Expansion
Otsuka Holdings Co., the parent of Japanese drug maker Otsuka Pharmaceutical Co. Ltd., has scheduled its long-planned initial public offering for December 15
Otsuka Plans $2.8 Billion IPO To Feed Global Expansion
Otsuka Holdings Co., the parent of Japanese drug maker Otsuka Pharmaceutical Co. Ltd., has scheduled its long-planned initial public offering for December 15
Otsuka Plans $2.8 Billion IPO To Feed Global Expansion
Still fueled by growth of the anti-psychotic Abilify, the Japanese pharma's parent company plans to list on the Tokyo Stock Exchange on December 15.